The PragmaClin team with Minister Andrew Parsons - Photo by Andrew Parsons
Today, we're very excited to be launching our own PragmaClin blog.
Here, we'll provide updates on our development progress, useful articles about Parkinson's Disease, and news about new developments in the field—all written by the wonderful and passionate people who work here.
For those who may be coming across us for the first time, we're PragmaClin, a digital health company created by Bronwyn Bridges & Gord Genge operating in the healthcare sector. When Gord was diagnosed with Parkinson's in 2019, he was shocked by the long wait-time for assessment and the lack of support for people living with Parkinson's. Bronwyn is a Ph.D. student at Memorial University and while conducting her research on Parkinson's, she met Gord and together they came up with an exciting new solution. Shortly after PragmaClin was incorporated and PRIMS was born.
PRIMS is our integrated software that monitors, analyzes and rates Parkinson's disease severity according to international standards. PRIMS collects data in real-time through cameras and surveys; wearable sensors are not required. The data collected will then be readily available to the patients, neurologists, and other support personnel. PRIMS will improve a clinician’s ability to manage disease progression by providing objective data that will support clinical treatment decisions.
We're in the process of preparing for our validation study in the UAE, which is set for later this month. If you've been following us for the past few years, you've actively seen our growth and how much we've expanded our reach and our team. Just this past year alone we've grown from 2 full-time members to over 12. We have plans to enter the UAE, Canada, US, and UK markets and this will help us achieve our vision of being a global leader in supporting neurological disorders through digital technology.
Members of the Roux Institute's Future of Healthcare Residency Program - Photo credits: Roux Institute
We've also had some incredible opportunities this past year to showcase PRIMS on a global scale. One of our more recent opportunities comes from The Roux Institute at Northeastern University. PragmaClin was accepted into the Future of Healthcare Founder Residency program which is designed to support digital health, healthcare technology, biotech, and clinical innovation founders at the earliest stages of their entrepreneurial journey. During this program, Bronwyn will be living in Maine to learn more about the US market.
This is just a brief snapshot of what we've been up to and we can't wait to show you more. We hope to have PRIMS validated soon so we can get clinicians, neurologists, and patients using it as fast as possible. In the meantime, sign up for our mailing list at the footer of our website. Then you can be the first to know when you can get your hands on PRIMS. You can expect posts in the coming weeks written by members of the PragmaClin team. If you have any questions and want to learn more, feel free to contact us.
We're incredibly grateful for your support, we couldn't have done this without you.